Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
₹ 272000 / 3200 Shares Shares
Minimum Investment
Invicta Diagnostic Limited IPO
Issues Price
₹80-85 per equity share
Invicta Diagnostic Limited IPO
Open Date
01 Dec 2025
Close Date
03 Dec 2025
Lot Size
1600
Min. Investment
₹ 272000
Issue Price
₹80-85
Listing Date
08 Dec 2025
Issues Size
33,08,800 shares(aggregating up to ₹28.12 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
3200 Shares
Offered To Public
3200 Shares
Invicta Diagnostic Limited IPO
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra. Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring: A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa. It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations. Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes: Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels. Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Founded In
2021
Managing Director
Dr. Ketan Jayantilal Jain
Parent Organization
Invicta Diagnostic Limited IPO
Application for Invicta Diagnostic Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹80-85 | ₹2,72,000 |
| Individual(max) | ₹80-85 | ₹2,72,000 |
| SHNI(min) | ₹80-85 | ₹4,08,000 |
| SHNI(max) | ₹80-85 | ₹9,52,000 |
| BHNI(min) | ₹80-85 | ₹10,88,000 |
Apply for all eligible candidates, Invicta Diagnostic Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
KSquare helped me invest in Indian markets with zero stress. Their NRI Corner is truly designed for people living abroad.
I started my NPS with KSquare last year, and the process was very smooth. I trust them with long-term goals.
Thanks to KSquare, I purchased my first car without loans. The SIP plan was perfectly calculated and aligned with my budget, making everything financially smooth and stress-free.
I feel empowered thanks to KSquare. Their NRI Corner is well-structured, and the financial advice is incredibly relevant and actionable.
Investing in NPS with KSquare has given me great peace of mind. Their platform is user-friendly and informative for long-term goals.
KSquare offered expert financial advice tailored to NRI needs. Their responsive team and secure platform earned my trust right away.
KSquare made it easy to access funds against my mutual investments. The process was fast, smooth, and completely transparent.
KSquare helped me borrow against my mutual funds with minimal paperwork. I’m impressed by their speed and support.
KSquare’s New Fund Offering updates are timely and insightful. I’ve participated in two NFOs already, and the results have been quite impressive and transparent.
Mutual fund investing with KSquare has been fantastic. I appreciate their attention to risk profiling and how they tailor recommendations. It’s an empowering experience.
FAQ's
Frequenlty Asked Question
What is the exit or withdrawal rule in NPS?
You can withdraw 60% of the corpus at retirement tax-free and use 40% to buy an annuity for regular income.
What happens if I stop my SIP before maturity?
You can withdraw your invested amount anytime. However, early exits might impact your long-term growth potential.
Which types of mutual funds are eligible for loans?
Typically, equity and debt mutual fund units held in demat form are eligible. KSquare helps confirm your fund’s eligibility instantly.
Can I start SIPs with a small monthly amount?
Yes, KSquare allows flexible SIP amounts, enabling anyone to start small and gradually increase investments based on comfort
How do I choose the right asset allocation in NPS?
KSquare helps you select between Active and Auto choices based on your age, risk appetite, and retirement goals.
Are NFOs better suited for long-term investors?
NFOs are ideal for long-term investors who can wait for the fund to build performance and portfolio over time.
How do I track my NPS account with KSquare?
You can log in to your KSquare dashboard to see real-time NAVs, contributions, and returns from your NPS account.
Does KSquare offer mutual funds for tax savings?
Yes, KSquare offers ELSS mutual funds, which are eligible for tax deductions under Section 80C up to ₹1.5 lakh.